Target intelligence / Profile preview

NS4B protein (Dengue virus) (NS4B)

Target
NS4B
Molecular classification
Enzyme, Other (integral membrane protein)
01

Overview

The NS4B protein of Dengue virus is a 27-kDa integral membrane protein with approximately 248 amino acids, featuring multiple transmembrane domains and localization to endoplasmic reticulum (ER)-derived membranes where it forms part of the viral replication complex. It plays essential roles in viral replication by interacting with other nonstructural proteins such as NS4A (via specific transmembrane regions), NS3 (regulating helicase activity), NS1, and NS2B, as well as forming homodimers and facilitating ER vesicle formation and membrane rearrangement. NS4B also engages host factors like vimentin, PERK, EMC, CypA, MAGT1, and VCP to support replication complex anchoring and protein folding. In disease, NS4B contributes to Dengue virus pathogenesis by evading innate immunity, including inhibition of type I interferon signaling, TBK1 phosphorylation, and stress granule formation, while promoting virus-induced ER alterations that enable efficient RNA replication. As a therapeutic target, NS4B is attractive for antivirals due to its lack of enzymatic activity (relying on protein interactions) and conservation across DENV serotypes, with studies pursuing inhibitors that disrupt key interactions like NS4A-NS4B or NS4B-NS3, though challenges include its dynamic structure, N-glycosylation, and host pathway crosstalk; no approved drugs exist, but cell-based assays support target-based discovery.

Other names
dengue virus nonstructural protein 4BDENV NS4B
02

Mechanism of action

Inhibition of NS4A-NS4B interaction, blocking NS4B dimerization, disruption of NS4B-NS3 interaction to impair helicase activity, interference with NS4B membrane topology or protein folding

03

Biological functions

Viral replicationHost immune response evasionEndoplasmic reticulum membrane rearrangementProtein-protein interactions
04

Disease associations

Infection (Dengue fever)
05

Safety considerations

Potential disruption of host ER membrane remodeling and unfolded protein responseinduction of apoptosis via PERK dimerizationoff-target effects on host proteins like EMC, CypA, VCPchallenges in broad-spectrum activity due to low homology with other flaviviruses
06

Interacting drugs

None approved

1 more in the full profile.

Beyond the preview

Go deeper on NS4B protein (Dengue virus) (NS4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NS4B protein (Dengue virus) (NS4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call